133 related articles for article (PubMed ID: 3600053)
1. Sensitivity and resistance to chemotherapy in acute leukemia: correlation with in vitro drug uptake and lack of potentiation by verapamil.
Andersson BS; Beran M; Stuckey SE; McCredie KB; Mavligit GM
Med Oncol Tumor Pharmacother; 1987; 4(1):17-21. PubMed ID: 3600053
[TBL] [Abstract][Full Text] [Related]
2. The effects of verapamil and a tiapamil analogue, DMDP, on adriamycin-induced cytotoxicity in P388 adriamycin-resistant and -sensitive leukemia in vitro and in vivo.
Radel S; Bankusli I; Mayhew E; Rustum YM
Cancer Chemother Pharmacol; 1988; 21(1):25-30. PubMed ID: 3342462
[TBL] [Abstract][Full Text] [Related]
3. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
de Jong S; Zijlstra JG; de Vries EG; Mulder NH
Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222
[TBL] [Abstract][Full Text] [Related]
4. A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia.
Keating MJ; Gehan EA; Smith TL; Estey EH; Walters RS; Kantarjian HM; McCredie KB; Freireich EJ
J Clin Oncol; 1987 May; 5(5):710-21. PubMed ID: 3553435
[TBL] [Abstract][Full Text] [Related]
5. Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development.
Zwelling LA; Mitchell MJ; Satitpunwaycha P; Mayes J; Altschuler E; Hinds M; Baguley BC
Cancer Res; 1992 Jan; 52(1):209-17. PubMed ID: 1309224
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
[TBL] [Abstract][Full Text] [Related]
8. Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
Zwelling LA; Michaels S; Erickson LC; Ungerleider RS; Nichols M; Kohn KW
Biochemistry; 1981 Nov; 20(23):6553-63. PubMed ID: 6895473
[TBL] [Abstract][Full Text] [Related]
9. Effects of verapamil on uptake and in vitro toxicity of anthracyclines in human leukemic blast cells.
Tidefelt U; Sundman-Engberg B; Paul C
Eur J Haematol; 1988 May; 40(5):385-95. PubMed ID: 3163975
[TBL] [Abstract][Full Text] [Related]
10. New drugs in the treatment of acute and chronic leukemia with some emphasis on m-AMSA.
Jehn U; Heinemann V
Anticancer Res; 1991; 11(2):705-11. PubMed ID: 2064323
[TBL] [Abstract][Full Text] [Related]
11. Analysis of nuclear m-AMSA content by DNA fluorochrome competition.
Andersson BS; Beran M; Barlogie B; Van NT; McCredie KB
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):883-9. PubMed ID: 3464432
[TBL] [Abstract][Full Text] [Related]
12. Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.
Odaimi M; Andersson BS; McCredie KB; Beran M
Cancer Res; 1986 Jul; 46(7):3330-3. PubMed ID: 3754787
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines.
Snow K; Judd W
Br J Cancer; 1991 Jan; 63(1):17-28. PubMed ID: 1989661
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of a human myelogenous leukemia cell line resistant to 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide.
Beran M; Andersson BS
Cancer Res; 1987 Apr; 47(7):1897-904. PubMed ID: 3469023
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA
Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713
[TBL] [Abstract][Full Text] [Related]
16. Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions.
Zwelling LA; Mayes J; Hinds M; Chan D; Altschuler E; Carroll B; Parker E; Deisseroth K; Radcliffe A; Seligman M
Biochemistry; 1991 Apr; 30(16):4048-55. PubMed ID: 1850298
[TBL] [Abstract][Full Text] [Related]
17. Effect of amsacrine on ara-CTP cellular pharmacology in human leukemia cells during high-dose cytarabine therapy.
Plunkett W; Nowak B; Keating MJ
Cancer Treat Rep; 1987 May; 71(5):479-83. PubMed ID: 3567973
[TBL] [Abstract][Full Text] [Related]
18. The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
Bakic M; Beran M; Andersson BS; Silberman L; Estey E; Zwelling LA
Biochem Biophys Res Commun; 1986 Jan; 134(2):638-45. PubMed ID: 3004458
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcium influx blocker verapamil on adriamycin-induced cytotoxicity in leukemia cells in vitro.
Mircheva JJ; Tsuruo T
Acta Physiol Pharmacol Bulg; 1989; 15(4):3-8. PubMed ID: 2634901
[TBL] [Abstract][Full Text] [Related]
20. [Study on the toxicity and antitumor activity of adriamycin-DNA and amsacrine-DNA complexes in mice].
Zhang XG; Wu DZ
Yao Xue Xue Bao; 1992; 27(11):801-5. PubMed ID: 1300022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
